Integrated Core Strategies (US) LLC 13D and 13G filings for Enanta Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-17 4:31 pm Sale | 2024-09-30 | 13G | ENANTA PHARMACEUTICALS INC ENTA | Integrated Core Strategies (US) LLC | 731,295 3.500% | -583,654 (-44.39%) | Filing |
| 2024-01-11 4:15 pm Purchase | 2024-01-05 | 13G | ENANTA PHARMACEUTICALS INC ENTA | Integrated Core Strategies (US) LLC | 1,314,949 6.200% | 290,273 (+28.33%) | Filing |
| 2023-11-16 4:31 pm Purchase | 2023-11-07 | 13G | ENANTA PHARMACEUTICALS INC ENTA | Integrated Core Strategies (US) LLC | 1,024,676 4.900% | 1,024,676 (New Position) | Filing |